Product
TU7710
1 clinical trial
3 indications
Indication
Hemophilia AIndication
Hemophilia BIndication
CoagulopathiesClinical trial
A First-in-Human (FIH), Randomized, Double-Blind, Placebo-controlled, Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of TU7710 Following Single, Ascending, Intravenous, Dose Administration in Warfarin Anti-coagulated Healthy Male SubjectsStatus: Recruiting, Estimated PCD: 2024-02-01